StockData
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

GUIDED THERAPEUTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026

Market cap
$15.45M
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Guided Therapeutics's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Auctus Fund Management LLC5,804,8659.90%13G (passive) amendmentSep 30, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Richard P. BlumbergDirector, 10% owner13,543,13014.03%May 5, 2026
Michael C. JamesDirector1,001,8631.04%Apr 7, 2026
John E. ImhoffDirector, 10% owner21,252,67322.01%Apr 7, 2026
Alan GrujicDirector1,817,5411.88%Apr 7, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
John E. Imhoff
Director, 10% owner
Mar 31, 2026Conversion+157,417$0.07$11.02K21,252,673
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other+1,040,000––10,020,273
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other−88––0
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other+19,038––10,039,311
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other+352,000––10,391,311
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other−260––0
Richard P. Blumberg
Director, 10% owner
Mar 26, 2026Other+56,093––8,980,273
John E. Imhoff
Director, 10% owner
Mar 26, 2026Other−10––0
John E. Imhoff
Director, 10% owner
Mar 26, 2026Other+2,157––21,055,256
John E. Imhoff
Director, 10% owner
Mar 26, 2026Other+40,000––21,095,256
John E. Imhoff
Director, 10% owner
Feb 27, 2026Other−100––0
John E. Imhoff
Director, 10% owner
Feb 27, 2026Other+400,000––20,897,013
John E. Imhoff
Director, 10% owner
Feb 27, 2026Conversion+156,086$0.07$10.93K21,053,099
Richard P. Blumberg
Director, 10% owner
Feb 25, 2026Option exercise+1,000,000––8,924,180
John E. Imhoff
Director, 10% owner
Feb 25, 2026Option exercise+500,000––20,497,013
Michael C. James
Director
Feb 25, 2026Option exercise+100,000––653,495
John E. Imhoff
Director, 10% owner
Feb 2, 2026Conversion+312,720$0.07$21.89K19,997,013
John E. Imhoff
Director, 10% owner
Jan 5, 2026Other+25,338––19,684,293
John E. Imhoff
Director, 10% owner
Dec 18, 2025Conversion+195,460$0.07$13.68K19,658,955
Alan Grujic
Director
Aug 29, 2025Buy+152,108––1,817,541
John E. Imhoff
Director, 10% owner
Aug 29, 2025Buy+166,667$0.18$30.00K19,463,495
Michael C. James
Director
Aug 29, 2025Buy+27,778$0.18$5.00K553,495
Alan Grujic
Director
Aug 21, 2025Other+200,000––1,665,433
Alan Grujic
Director
Aug 21, 2025Other+17,408––1,465,433
Alan Grujic
Director
Aug 21, 2025Other−50––0
John E. Imhoff
Director, 10% owner
Aug 21, 2025Other−300––100
John E. Imhoff
Director, 10% owner
Aug 21, 2025Other+104,448––18,096,828
John E. Imhoff
Director, 10% owner
Aug 21, 2025Other+1,200,000––19,296,828
Richard P. Blumberg
Director, 10% owner
Aug 21, 2025Other+932,000––7,924,180
Richard P. Blumberg
Director, 10% owner
Aug 21, 2025Other−233––0
Richard P. Blumberg
Director, 10% owner
Aug 21, 2025Other+81,121––6,992,180
Richard P. Blumberg
Director, 10% owner
Apr 10, 2025Other+55,853––6,911,059
Richard P. Blumberg
Director, 10% owner
Apr 10, 2025Other+165,481––6,855,206
John E. Imhoff
Director, 10% owner
Apr 10, 2025Other+6,365––17,992,380
John E. Imhoff
Director, 10% owner
Apr 10, 2025Other+6,365––17,992,380
John E. Imhoff
Director, 10% owner
Mar 18, 2025Buy+1,000,000$0.10$100.00K17,722,946
John E. Imhoff
Director, 10% owner
Mar 18, 2025Buy+263,069$0.10$26.31K17,986,015
John E. Imhoff
Director, 10% owner
Mar 18, 2025Buy+263,069$0.10$26.31K17,986,015
John E. Imhoff
Director, 10% owner
Mar 18, 2025Buy+1,000,000$0.10$100.00K17,722,946
Michael C. James
Director
Mar 18, 2025Buy+150,000$0.10$15.00K262,772
Michael C. James
Director
Mar 18, 2025Buy+262,945$0.10$26.29K525,717
John E. Imhoff
Director, 10% owner
Mar 13, 2025Buy+150––400
John E. Imhoff
Director, 10% owner
Mar 11, 2025Other−286––0
John E. Imhoff
Director, 10% owner
Mar 11, 2025Other+2,258,690$0.13$293.63K16,722,946
John E. Imhoff
Director, 10% owner
Mar 11, 2025Other−286––0
John E. Imhoff
Director, 10% owner
Mar 11, 2025Other+2,258,690$0.13$293.63K16,722,946
John E. Imhoff
Director, 10% owner
Mar 7, 2025Buy+286––286
John E. Imhoff
Director, 10% owner
Mar 7, 2025Buy+286––286
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other+4,801,500$0.50$2.40M14,464,256
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other−2,400.75––0
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other−300––0
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other+900,000––9,662,756
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other+4,801,500$0.50$2.40M14,464,256
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other−300––0
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other−2,400.75––0
John E. Imhoff
Director, 10% owner
Mar 6, 2025Other+900,000––9,662,756
John E. Imhoff
10% owner
Jan 17, 2025Other+35,312––8,762,756
John E. Imhoff
Director, 10% owner
Dec 18, 2024Buy+1,615,385––8,727,444
John E. Imhoff
Director, 10% owner
Oct 15, 2024Other+36,161––7,112,059
Richard P. Blumberg
Director, 10% owner
Oct 14, 2024Other+400,000––6,689,725

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.